Jonathan Barratt, MD: Targeting the Alternative Complement Pathway in IgAN with Iptacopan

Retrieved on: 2024-04-15 21:50:08

Tags for this article:

Click the tags to see associated articles and topics

Jonathan Barratt, MD: Targeting the Alternative Complement Pathway in IgAN with Iptacopan. View article details on hiswai:

Excerpt

Barratt discusses the potential of targeting the alternative pathway for controlling inflammation and the significance of the new APPLAUSE-IgAN data.

Article found on: www.hcplive.com